Robert P. Edwards, MD | Authors

TLC Consulting, Inc.

16 Summerhill Avenue

Suite 1

Articles

The Legacy of Intraperitoneal Therapy in Ovarian Cancer: Why Are We Never Satisfied With the Answer

September 15, 2015

The evidence suggests that few centers offer IP therapy routinely. Why? The answer may be that oncologists simply don’t know what to do. There have been three completely distinct regimens, none of which has been used in the outpatient setting.